Utah regulators have authorized New York-based startup Nolla Health to use an AI system to evaluate patients and issue initial acne prescriptions without prior human review, in a closely watched test of autonomous medical decision-making.
The program operates through the Nolla Derm app, where patients complete a 10- to 15-minute questionnaire and facial scan. It is part of Utah’s AI sandbox program, which allows regulators to temporarily waive certain requirements while testing new technologies.
The company says the service could make dermatology more affordable, with the app costing $4.99 per month compared with typical visits costing $150 to $300. However, American Medical Association CEO John Whyte has argued that AI tools should not practice medicine autonomously. Nolla plans to expand beyond acne treatment.
Related Tweet:
An AI-based healthcare startup will start offering dermatology prescriptions to Utah patients without a doctor's oversight. https://t.co/dalmsQdER9
— Bloomberg (@business) October 5, 2026
Also Read:
TIPP Staff
